On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayJan 20, 2017 12:29 pm

NetworkNewsBreaks – MagneGas Corporation (NASDAQ: MNGA) Creates New Revenue Streams in Florida’s Leisure Markets with Commercial Sale of CO2

MagneGas (NASDAQ: MNGA) is a technology company engaged in the renewable resources and environmental solutions industries. The company is known primarily for its patented process that converts various renewables and liquid wastes into MagneGas fuels for use as an alternative to natural gas or for metal cutting. MagneGas recently announced the expansion of its product offering to include the commercial sale of carbon dioxide (CO2), which is primarily used in the food, oil and chemical industries. Recognizing CO2 as a complimentary product offering to its current industrial gas segment and retail infrastructure, the company anticipates that the sale of CO2…

Continue Reading

FridayJan 20, 2017 12:27 pm

NetworkNewsBreaks – Ballard Power Systems (NASDAQ: BLDP) Geared to Fight China’s Smog Problem

China’s hazardous levels of air pollution have officials in various cities calling for temporary closures in highways, flights and industrial plants. Meanwhile, Ballard Power Systems (NASDAQ: BLDP) is working with Guangdong Nation Synergy Hydrogen Power Technology Co. Ltd to establish fuel cell stack production in the City of Yunfu in the Guangdong Province. Under an agreement reached in October 2016, Ballard will receive $170 million over five years for a working deal that includes the creation of a joint venture who will manufacture and sell FCvelocity®-9SSL stacks to be used primarily in locally-assembled fuel cell engines to provide propulsion power…

Continue Reading

FridayJan 20, 2017 12:23 pm

NetworkNewsBreaks – The Alkaline Water Company Inc. (WTER) Continues Rapid Expansion; Lands 2 More Retail Grocery Chains

The Alkaline Water Company (OTCQB: WTER), developer of the innovative bottled alkaline drinking water Alkaline88, recently announced it will shelve its products in two additional retail grocery chains: Fresh Thyme Farmers Markets and Food Depot. Alkaline88 is now available in more than 20,000 stores throughout the United States. The company is consistently adding news stores to its roster, and in early November said more than 1,800 additional stores in the Southeast are now carrying the Alkaline88 brand – which is expected to increase fiscal 2018 revenue by at least 8%. To learn more visit www.thealkalinewaterco.com About The Alkaline Water Company…

Continue Reading

FridayJan 20, 2017 12:22 pm

NetworkNewsBreaks – Advanced Medical Isotope Corp. (ADMD) Targets Cancer, $1B Market with Brachytherapy Devices

Advanced Medical Isotope (OTC: ADMD) (“AMI”) develops cutting-edge brachytherapy devices for therapeutic applications, such as the Y-90 RadioGel™ device. Brachytherapy is the use of radiation to destroy cancerous tumors by placing a radiation source inside or next to the treatment area. AMI is in a booming industry, with the estimated annual sales of brachytherapy products exceeding $1 billion, about half of which are attributed to the United States. In October, the company reported that the first family pet, a cat, was treated for cancer with the company's pet version of the Y-90 RadioGel™ device. The study outcome data will be…

Continue Reading

ThursdayJan 19, 2017 12:29 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 19, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DELT 84.99% – News: Posts unaudited Q4 2016 sales results SGLB 64.40% – News: Enters long-term commercial agreement for PrintRite3D® with major European OEM NFEC 21.46% – News: Announces business cooperation with Indian Flucon International Co. Ltd. VRAY 17.52% – News: First ViewRay MRIdian Linac purchased by German Research Foundation since CE mark approval LXRP 14.59% – News: Releases positive results from cannabinoid tablet development trial with NeutriSci BHTG 13.46% – News: Launches updated…

Continue Reading

ThursdayJan 19, 2017 12:26 pm

NetworkNewsBreaks – Celsius Holdings, Inc. (CELH) Sees Strength in International Presence, Sales

Celsius Holdings (OTCQX: CELH) is science-based beverage company actively expanding its international presence. The company most recently launched its CELSIUS® fitness drink into supermarkets, convenience and specialty stores and fitness centers in Singapore.  News of this expansion followed a record third-quarter performance, marked by sales of $6.7 million, up 82% YoY. While domestic revenue grew 53%, the company saw particular strength in international sales, which increased 147%. Celsius in November also partnered with the A.S. Watson Group (ASW) for distribution of CELSIUS in Hong Kong and Macau, providing a foothold in the growing Chinese energy drink category. To learn more…

Continue Reading

ThursdayJan 19, 2017 11:56 am

NetworkNewsBreaks – CV Sciences, Inc. (CVSI) Mines the Benefits of Science and Nature to Build Cannabidiol-Based Portfolio

The strategic integration of science and nature is the cornerstone of operations at CV Sciences (OTCQB: CVSI). Its Pharmaceuticals Division, for example, is developing synthetically formulated cannabidiol (CBD)‐based medicine for which the company is pursuing FDA approval. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for the treatment of a range of medical conditions. The company’s initial drug candidate (CVSI-007) is a chewing gum containing nicotine and synthetic CBD to support cessation of smokeless tobacco use and addiction. Focusing on enhancing the quality of life, CV Sciences’ Consumer Products Division delivers botanical-based CBD products such…

Continue Reading

ThursdayJan 19, 2017 11:53 am

NetworkNewsBreaks – PURE Bioscience, Inc. (PURE): 2017 Poised to be ‘Breakout Year’

Demonstrating the growing acceptance for its antimicrobial products, PURE Bioscience (OTCQB: PURE) recently posted first-quarter revenues of $531,000, up 186% year-over-year. Core food safety revenues increased 902% year-over-year, an achievement the company attributes to the accelerating momentum of its focused food safety strategy. PURE is pursuing regulatory approval for use of PURE Control in poultry online reprocessing, and said it expects FDA and USDA approvals in the second quarter of 2017. In its earnings release, company CEO Hank Lambert forecasts calendar 2017 as PURE’s “breakout year.” To learn more visit www.purebio.com About PURE Bioscience, Inc. PURE Bioscience, Inc. is focused…

Continue Reading

ThursdayJan 19, 2017 11:51 am

NetworkNewsBreaks – Sphere 3D (NASDAQ: ANY) Inks Deal to Acquire HVE and Unified ConneXions; Shares Higher

Shares of Sphere 3D (NASDAQ: ANY) are up 28% after the data management company said it will acquire HVE (Hybrid Virtualization Engine) ConneXions and its sister company, Unified ConneXions, Inc., which achieved combined virtualization revenue of more than $7 million for calendar year 2016. The acquired companies’ products, technologies and professional services will expand Sphere 3D’s virtualization practice and increase its ability to accelerate the delivery of hybrid cloud solutions. The acquisition is anticipated to close before January 31, 2017, and is expected to be accretive in the first quarter of 2017.  “UCX has exceptional leadership teams, innovative technology, industry…

Continue Reading

ThursdayJan 19, 2017 11:48 am

NetworkNewsBreaks – Rosetta Genomics Ltd. (NASDAQ: ROSG) Sets Stage for Value Creation in 2017

Rosetta Genomics (NASDAQ: ROSG) is an international company leveraging a growing IP portfolio to develop and commercialize microRNA-based and other molecular diagnostic programs in cancer and various other indications. In 2016, Rosetta was primarily focused on the commercial launch of its Reveal assay for the classification of indeterminate thyroid nodules, and it signed an exclusive distribution agreement with Rhenium Ltd. for the sales and marketing of Reveal in Israel. In a December earnings release, Rosetta Genomics said it expects FY2017 RosettaGX Reveal revenue to be between $4 million and $5 million. The company is also advancing a number of other…

Continue Reading

Contact us: 212.418.1217